WATERTOWN, Mass., April 17, 2026 (GLOBE NEWSWIRE) — Lyra Therapeutics, Inc. (the “Company”) nowadays introduced its aim to voluntarily record a Shape 25 Notification of Delisting with the U.S. Securities and Alternate Fee (the “SEC”) on Monday, April 20, 2026, to take away its commonplace inventory from list and registration on The Nasdaq Inventory Marketplace LLC (“Nasdaq”). As prior to now disclosed, buying and selling within the Corporate’s commonplace inventory was once suspended through Nasdaq on March 17, 2026. Even supposing Nasdaq has indicated it intends to record its personal Shape 25 in any case inner procedural sessions have run, it has now not but accomplished so. The Corporate is subsequently voluntarily submitting Shape 25 with a purpose to continue with deregistration. The Corporate’s commonplace inventory is recently quoted at the Crimson Restricted Marketplace. This press unlock is being issued in compliance with Rule 12d2-2(c) underneath the Securities Alternate Act of 1934, as amended (the “Exchange Act”).
Ahead-Taking a look Statements
This press unlock comprises forward-looking statements throughout the that means of the Non-public Securities Litigation Reform Act of 1995. Ahead-looking statements on this press unlock come with, however don’t seem to be restricted to, statements in regards to the Corporate’s aim to record Shape 25 and the predicted timing thereof, the predicted effectiveness of the delisting, the Corporate’s plans to record a Shape 15 to terminate registration and droop reporting responsibilities, and the predicted suspension and termination of periodic reporting necessities. Those statements contain identified and unknown dangers, uncertainties, and different components that can motive precise effects to range materially from the ones expressed or implied in such statements. Necessary components that would motive precise effects to range materially from the ones mirrored within the Corporate’s forward-looking statements are mentioned underneath the heading “Risk Factors” within the Corporate’s Annual Document on Shape 10-Ok for the fiscal yr ended December 31, 2025, and in different filings the Corporate makes with the SEC every now and then. The Corporate undertakes no legal responsibility to publicly replace or revise any forward-looking statements, whether or not because of new data, long term occasions, or another way, except for as required through appropriate regulation.
